Profiel
Andrew H.
Chang worked as a Director of Investor Relations at Astellas Gene Therapies, Inc. and later as the Head of Investor Relations and Corporate Communication at Applied Molecular Transport, Inc. from 2020 to 2023.
Eerdere bekende functies van Andrew H. Chang
Bedrijven | Functie | Einde |
---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Investor Relations Contact | 27-12-2023 |
AUDENTES THERAPEUTICS, INC. | Investor Relations Contact | 01-01-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |